AtheroNova Inc. — Form D/A
AtheroNova Inc. of IRVINE, CA, a company, filed a Form D amendment with the SEC on 2014-03-03. The offering totals $2.0M, of which $1.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-03-03
- Form: D/A
- Accession: 0001377053-14-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.9M
- Remaining: $94K
- Investors: 31
- Date of first sale: 2014-01-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-210541
Issuer
- Name: AtheroNova Inc.
- CIK: 0001377053
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2301 DUPONT DRIVE, SUITE 525, IRVINE, CA, 92612
- Phone: (949) 525-5471
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Alexander W Polinsky | Director | Irvine, CA |
| Thomas W Gardner | Director | Irvine, CA |
| Thomas W Gardner | Executive Officer | Irvine, CA |
| Johan M Spoor | Director | Irvine, CA |
| Paul W DiPerna | Director | Irvine, CA |
| Boris W Ratiner | Director | Irvine, CA |
| Gary W Freeman | Director | Irvine, CA |
| Mark Selawski | Executive Officer | Irvine, CA |
| Fred W Knoll | Director | Irvine, CA |
| Chaim W Davis | Director | Irvine, CA |
| Alexander W Polinksy | Director | Irvine, CA |
| Filiberto W Zadini | Director | Irvine, CA |
Other filings by this issuer (7)
More